jejuni 81-176 sequences; restriction recognition sites introduced for cloning purposes are underlined, complementary fragments of primers Cjj46mwR and Cjj43mwL are marked with italics. Point mutated VE821 nucleotides in primers are marked with small letters. Orientation of the primers

Ulixertinib (Fwd states for forward/Rev – for reverse) refers to the orientation of particular C. jejuni gene studied. RT-Cj primer was designed on the basis of C. coli 72Dz/92 dsbI nucleotide sequence (there are 2 nucleotide changes compared to the nucleotide sequence of its orthologue from C. jejuni 81-176). All vectors containing transcriptional fusions of putative dsb gene promoter regions

with a promotorless lacZ gene were constructed using the pMW10 E. coli/C. jejuni shuttle vector. DNA fragments were amplified selleck products from C. jejuni 81-176 chromosomal DNA with appropriate pairs of primers (listed in Table 2). Next, PCR products were cloned in the pGEM-T Easy vector (Promega), excised by restriction enzymes and subsequently cloned into pMW10, forming transcriptional fusions with the downstream promoterless lacZ reporter gene. Correct construction of the resulting shuttle plasmids was confirmed by restriction analysis and sequencing. Morin Hydrate All recombinant

plasmids, as well as the empty pMW10, were introduced into C. jejuni 480 cells by electroporation. Construction of a pUWM1072 plasmid containing dsbI without dba under its native promoter was achieved by PCR-amplification of the 520 bp chromosomal DNA fragments containing the dba-dsbI promoter sequences (primer pair Cj19LX-2 – Cj18Nde-Rev) and cloning it into pBluescript II SK (Stratagene), using XbaI/PstI restriction enzymes. Subsequently the dsbI coding sequence (1792 bp) was PCR-amplified using the Cj17Nde – Cj16RS primer pair, cloned into pGEM-T Easy (Promega) and finally, using NdeI/SalI restriction enzymes, transferred into pUWM1072 in the native orientation, generating the plasmid pUWM1100. The whole insert (2316 bp) was then cloned into a shuttle E. coli/C. jejuni vector pRY107 [27] using SalI/XbaI restriction enzymes. The resulting, plasmid pUWM1103, whose correct construction was verified by sequencing, was used for complementation assays in C. jejuni Δdba-dsbI::cat mutant cells. Point mutations were generated using a Quick-Change site-directed mutagenesis kit, following the supplier’s recommendations (Stratagene).